Clinical Trials on Atypical Anorexia Nervosa
Total 0 results
Nothing found
Sponsors and Collaborators
- Donna Hammond, PhD
- The First Affiliated Hospital of Air Force Medicial University
- Alfred Hospital Intensive Care Unit Australia
- Cooperative Clinical Drug Research and Development AG (CCDRD AG)
- Stefania Basili
- Shamir Optical Industry Ltd
- University of Natural Resources and Life Sciences, Vienna, Austria
- Faculdade de Medicina da Universidade do Porto (FMUP)
- Institute of Antibiotics, Huashan Hospital, Fudan University
- Jikei University School of Medicine
- Delosis Limited
- Prof. Jürgen Kuschyk, M.D
- RINO ZUID
- Research Unit of General Practice, Odense
- InfraScan, Inc.
- Centre Hospitalier de Bastia
- Jiajie Chen
- IDRI Corporation
- Canadian Hemophilia Society
- Deutsche Arthrose-Hilfe
- View Full List
Medical Conditions
- Surgery Induced Tissue Adhesions
- Acute Myocardial Infarction, of Inferolateral Wall
- Ovarian Aging
- Community-Acquired Staphylococcus Aureus
- Asian Consortium
- Colonic Adenoma
- Robot-assisted Laparoscopic Prostatectomy Under General Anesthesia
- Reduction, Weight
- UP in Online Group Format
- Oxidative Stress in Patient With Haemoglobinopathy and Affect it of Endocrine System
- Insulin-Dependent Diabetes Mellitus
- Refractory Transformed B-Cell Non-Hodgkin Lymphoma
- Incompetence, Functional
- Subgluteal Sciatic Block
- Sepsis and Coagulopathy
- Sensory Reconstruction of Digits
- Neovascular Age-related Macular Degeneration(nAMD)
- Open Reduction and Internal Fixation
- HIV Related Insulin Resistance
- Autosomal Dominant Hypocalcaemia
- View Full List
Drug Interventions
- Nanoliposomal Irinotecan
- HLX23
- Hypertonic saline
- Domperidone
- LIS 18 U
- JR-141
- Arm 1 - GEH120714 (18F) Injection
- Chlorcyclizine HCl
- Radioligand (11C)AZD2184
- INCB7839
- Epoetin beta (NeoRecormon®)
- Propranolol Hydrochloride Extended Release Capsules 160 mg
- Gemcitabine (mg/m²)
- Atorvastatin, 10mg, 20mg, 40mg
- Rosuvastatin calcium tablets
- PF regimen (cis-platinum ; 5-fluorouracil ) combined with PD-1 inhibitors（pembrolizumab）
- Moxifloxacin
- Sorafenib and OSI-906
- Prucalopride
- 13 valent pneumococcal conjugate vaccine and 23 valent pneumococcal polysaccharide vaccine
- View Full List
CROs by country
- Contract Research Organizations in Armenia
- Contract Research Organizations in Australia
- Contract Research Organizations in Belgium
- Contract Research Organizations in Brazil
- Contract Research Organizations in Cote d'Ivoire
- Contract Research Organizations in Egypt
- Contract Research Organizations in Gambia
- Contract Research Organizations in Kuwait
- Contract Research Organizations in Morocco
- Contract Research Organizations in Paraguay
- Contract Research Organizations in Poland
- Contract Research Organizations in Portugal
- Contract Research Organizations in Zimbabwe
- CRO list by country